139 related articles for article (PubMed ID: 32259515)
1. Mutational heterogeneity between different regional tumour grades of clear cell renal cell carcinoma.
Ferronika P; Kats-Ugurlu G; Haryana SM; Utoro T; Rinonce HT; Danarto R; de Lange K; Terpstra MM; Sijmons RH; Westers H; Kok K
Exp Mol Pathol; 2020 Aug; 115():104431. PubMed ID: 32259515
[TBL] [Abstract][Full Text] [Related]
2. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
3. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
5. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
6. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
[TBL] [Abstract][Full Text] [Related]
7. Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.
Xi Y; Yuan Q; Zhang Y; Madhuranthakam AJ; Fulkerson M; Margulis V; Brugarolas J; Kapur P; Cadeddu JA; Pedrosa I
Eur Radiol; 2018 Jan; 28(1):124-132. PubMed ID: 28681074
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
Hakimi AA; Chen YB; Wren J; Gonen M; Abdel-Wahab O; Heguy A; Liu H; Takeda S; Tickoo SK; Reuter VE; Voss MH; Motzer RJ; Coleman JA; Cheng EH; Russo P; Hsieh JJ
Eur Urol; 2013 May; 63(5):848-54. PubMed ID: 23036577
[TBL] [Abstract][Full Text] [Related]
9. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.
Sankin A; Hakimi AA; Mikkilineni N; Ostrovnaya I; Silk MT; Liang Y; Mano R; Chevinsky M; Motzer RJ; Solomon SB; Cheng EH; Durack JC; Coleman JA; Russo P; Hsieh JJ
Cancer Med; 2014 Dec; 3(6):1485-92. PubMed ID: 25124064
[TBL] [Abstract][Full Text] [Related]
10. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
Gerlinger M; Quezada SA; Peggs KS; Furness AJ; Fisher R; Marafioti T; Shende VH; McGranahan N; Rowan AJ; Hazell S; Hamm D; Robins HS; Pickering L; Gore M; Nicol DL; Larkin J; Swanton C
J Pathol; 2013 Dec; 231(4):424-32. PubMed ID: 24122851
[TBL] [Abstract][Full Text] [Related]
11. PBRM1 and BAP1 as novel targets for renal cell carcinoma.
Brugarolas J
Cancer J; 2013; 19(4):324-32. PubMed ID: 23867514
[TBL] [Abstract][Full Text] [Related]
12. A novel highly frequent single‑nucleotide polymorphism site of cadherin 23 in clear cell renal cell carcinoma with sarcomatoid differentiation based on whole exome sequencing.
Yu W; Wang X; Wang Y; Jiang Y; Zhang W; Shi H; Li Y
Oncol Rep; 2020 Aug; 44(2):735-746. PubMed ID: 32468012
[TBL] [Abstract][Full Text] [Related]
13. Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity.
Hoefflin R; Lahrmann B; Warsow G; Hübschmann D; Spath C; Walter B; Chen X; Hofer L; Macher-Goeppinger S; Tolstov Y; Korzeniewski N; Duensing A; Grüllich C; Jäger D; Perner S; Schönberg G; Nyarangi-Dix J; Isaac S; Hatiboglu G; Teber D; Hadaschik B; Pahernik S; Roth W; Eils R; Schlesner M; Sültmann H; Hohenfellner M; Grabe N; Duensing S
Nat Commun; 2016 Jun; 7():ncomms11845. PubMed ID: 27291893
[TBL] [Abstract][Full Text] [Related]
14. Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma.
Verhoest G; Patard JJ; Fergelot P; Jouan F; Zerrouki S; Dreano S; Mottier S; Rioux-Leclercq N; Denis MG
Urol Oncol; 2012; 30(4):469-75. PubMed ID: 20863722
[TBL] [Abstract][Full Text] [Related]
15. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
Köhn L; Svenson U; Ljungberg B; Roos G
Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
[TBL] [Abstract][Full Text] [Related]
16. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
van der Mijn JC; Eng KW; Chandra P; Fernandez E; Ramazanoglu S; Sigaras A; Oromendia C; Gudas LJ; Tagawa ST; Nanus DM; Faltas BF; Beltran H; Sternberg CN; Elemento O; Sboner A; Mosquera JM; Molina AM
Mol Oncol; 2022 Jun; 16(12):2384-2395. PubMed ID: 35231161
[TBL] [Abstract][Full Text] [Related]
17. Clear cell renal cell carcinoma with prominent microvascular hyperplasia: Morphologic, immunohistochemical and molecular-genetic analysis of 7 sporadic cases.
Alaghehbandan R; Limani R; Ali L; Rogala J; Vanecek T; Steiner P; Hajkova V; Kuthi L; Slisarenko M; Michalova K; Pivovarcikova K; Hora M; Pitra T; Michal M; Hes O
Ann Diagn Pathol; 2022 Feb; 56():151871. PubMed ID: 34847388
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
[TBL] [Abstract][Full Text] [Related]
19. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.
Strauss P; Marti HP; Beisland C; Scherer A; Lysne V; Leh S; Flatberg A; Koch E; Beisvag V; Landolt L; Skogstrand T; Eikrem Ø
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
